VWM
TNYA icon

Vermillion Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Vermillion Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11K Hold
1,500
– – ﹤0.01% 1476
2026
Q1 		$1.04K Buy
+1,500
New +$1.11K ﹤0.01% 807

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Vermillion Wealth Management's TNYA Position: Q2 2026 in Review

Vermillion Wealth Management held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 1,500 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Vermillion Wealth Management first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Vermillion Wealth Management held 1,500 shares of Tenaya Therapeutics worth $1.11K as of Q2 2026.
  • Vermillion Wealth Management left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1476 holding.
  • Vermillion Wealth Management first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.